High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): Cytogenetic features, clinical characteristics and outcome

Leukemia

Volumn 28, Issue 7, 2014, Pages 1511-1518

  Chilton, L ^a   Buck, G ^b   Harrison, C J ^a   Ketterling, R P ^c   Rowe, J M ^d   Tallman, M S ^e   Goldstone, A H ^f   Fielding, A K ^g   Moorman, A V ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MAYO CLINIC   (United States)

^d SHAARE ZEDEK MEDICAL CENTER   (Israel)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

acute lymphoblastic leukaemia; adolescents; adults; chromosomal abnormalities; high hyperdiploidy; prognosis

Indexed keywords

IMATINIB;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHILDHOOD LEUKEMIA; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 14; CHROMOSOME 17; CHROMOSOME 17Q; CHROMOSOME 18; CHROMOSOME 19; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME 21; CHROMOSOME 22; CHROMOSOME 4; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME DELETION; CYTOGENETICS; DIPLOIDY; FEMALE; HIGH HYPERDIPLOIDY; HUMAN; ISOCHROMOSOME; KARYOTYPE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; TRISOMY; X CHROMOSOME; Y CHROMOSOME;

ADOLESCENT; ADULT; AGED; ANEUPLOIDY; BONE MARROW; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; YOUNG ADULT;

EID: 84904054301     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.379     Document Type: Article

References (29)

1. Moorman AV. The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia. Blood Rev 2012 26 123-135.
2. Maia AT, Tussiwand R, Cazzaniga G, Rebulla P, Colman S, Biondi A et al. Identification of preleukemic precursors of hyperdiploid acute lymphoblastic leukemia in cord blood. Genes Chromosomes Cancer 2004 40 38-43.
3. Davidsson J, Paulsson K, Lindgren D, Lilljebjorn H, Chaplin T, Forestier E et al. Relapsed childhood high hyperdiploid acute lymphoblastic leukemia presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations. Leukemia 2010 24 924-931.
4. Paulsson K, Forestier E, Lilljebjorn H, Heldrup J, Behrendtz M, Young BD et al. Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2010 107 21719-21724.
5. Paulsson K, Johansson B. High hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 2009 48 637-660.
6. Sutcliffe MJ, Shuster JJ, Sather HN, Camitta BM, Pullen J, Schultz KR et al. High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia a Children's Oncology Group (COG) initiative. Leukemia 2005 19 734-740.
7. Moorman AV, Richards SM, Martineau M, Cheung KL, Robinson HM, Jalali GR et al. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood 2003 102 2756-2762.
8. Dastugue N, Suciu S, Plat G, Speleman F, Cave H, Girard S et al. Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable 58951 CLG-EORTC results. Blood 2013 121 2415-2423.
9. Paulsson K, Forestier E, Andersen MK, Autio K, Barbany G, Borgstrom G et al. High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols. Haematologica 2013 98 1424-1432.
10. Paulsson K, Harrison CJ, Andersen MK, Chilton L, Nordgren A, Moorman AV et al. Distinct patterns of gained chromosomes in high hyperdiploid acute lymphoblastic leukemia with t(119)(q23p13), t(922)(q34q22) or MLL rearrangements. Leukemia 2013 27 974-977.
11. Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008 111 1827-1833.
12. Fielding AK, Rowe JM, Richards SM, Buck G, Moorman AV, Durrant IJ et al. Prospective outcome data on 267 unselected patients with Philadelphiachromosome positive adult acute lymphoblastic leukaemia confirms superiority of allogeneic transplant over chemotherapy the pre-imatinib era Results from the international ALL trial MRC UKALLXII/ECOG2993. Blood 2009 113 4489-4496.
13. Moorman AV, Harrison CJ, Buck GA, Richards SM, Secker-Walker LM, Martineau M et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL) Analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 Trial. Blood 2007 109 3189-3197.
14. Fielding AK, Rowe JM, Buck G, Foroni L, Gerrard G, Litzow MR et al. UKALLXII/ECOG2993 addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. Blood 2013 e-pub ahead of print 25 November 2013 doi10.1182/blood-2013-09-529008.
15. Harrison CJ, Moorman AV, Barber KE, Broadfield ZJ, Cheung KL, Harris RL et al. Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia a UK Cancer Cytogenetics Group Study. Br J Haematol 2005 129 520-530.
16. Storring JM, Minden MD, Kao S, Gupta V, Schuh AC, Schimmer AD et al. Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen. Br J Haematol 2009 146 76-85.
17. Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia the GRAALL-2003 study. J Clin Oncol 2009 27 911-918.
18. Ramanujachar R, Richards S, Hann I, Goldstone A, Mitchell C, Vora A et al. Adolescents with acute lymphoblastic leukaemia outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer 2007 48 254-261.
19. GFCH. Cytogenetic abnormalities in adult acute lymphoblastic leukemia correlations with hematologic findings and outcome. A Collaborative Study of the Groupe Francais De Cytogenetique Hematologique. Blood 1996 87 3135-3142.
20. Martin Ramos ML, Lahuerta Palacios JJ, Martinez LJ, Gomez Rodriguez MJ, Moreno IA, Barreiro ME. Karyotype and prognosis in adult Spanish acute lymphoblastic leukemia. Haematologica 2001 86 438-439.
21. Mi JQ, Wang X, Yao Y, Lu HJ, Jiang XX, Zhou JF et al. Newly diagnosed acute lymphoblastic leukemia in China (II) prognosis related to genetic abnormalities in a series of 1091 cases. Leukemia 2012 26 1507-1516.
22. Gomez-Segui I, Cervera J, Such E, Martinez-Cuadron D, Luna I, Ibanez M et al. Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia. Ann Hematol 2012 91 19-25.
23. Heerema NA, Raimondi SC, Anderson JR, Biegel J, Camitta BM, Cooley LD et al. Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia. Genes Chromosomes Cancer 2007 46 684-693.
24. Heerema NA, Sather HN, Sensel MG, Zhang T, Hutchinson RJ, Nachman JB et al. Prognostic impact of trisomies of chromosomes 10, 17 and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (450 chromosomes). J Clin Oncol 2000 18 1876-1887.
25. Raimondi SC, Pui CH, Hancock ML, Behm FG, Filatov L, Rivera GK. Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia 1996 10 213-224.
26. Whitehead VM, Vuchich MJ, Lauer SJ, Mahoney D, Carroll AJ, Shuster JJ et al. Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (450 chromosomes) B-lineage acute lymphoblastic leukemia a Pediatric Oncology Group study. Blood 1992 80 1316-1323.
27. Chauvenet AR, Martin PL, Devidas M, Linda SB, Bell BA, Kurtzberg J et al. Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood a report from Children's Oncology Group Study P9201. Blood 2007 110 1105-1111.
28. Gruszka-Westwood AM, Horsley SW, Martinez-Ramirez A, Harrison CJ, Kempski H, Moorman AV et al. Comparative expressed sequence hybridization studies of high-hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 2004 41 191-202.
29. Roberts P, Burchill SA, Brownhill S, Cullinane CJ, Johnston C, Griffiths MJ et al. Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors a study by the United Kingdom Cancer Cytogenetics and the Children's Cancer and Leukaemia Group. Genes Chromosomes Cancer 2008 47 207-220.